- Home
- EBS vs NL Comparison
EBS vs NL Comparison
Compare EBS & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBS | NL |
|---|---|---|
| Founded | 1998 | 1891 |
| Country | United States | United States |
| Employees | 900 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 349.2M | 332.0M |
| IPO Year | 2006 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EBS | NL |
|---|---|---|
| Price | $6.81 | $6.99 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 15.6K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | ★ 125.83 | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $742,900,000.00 | $158,285,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | $25.52 |
| Revenue Growth | N/A | ★ 8.46 |
| 52 Week Low | $4.36 | $5.04 |
| 52 Week High | $14.06 | $8.60 |
Technical Indicators
Market Signals| Indicator | EBS | NL |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 57.55 |
| Support Level | $6.13 | $6.86 |
| Resistance Level | $7.05 | $7.27 |
| Average True Range (ATR) | 0.33 | 0.22 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 62.55 | 83.64 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
About NL NL Industries Inc.
NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.